Big corporations are acting mainly as sponsors.
They were backed by international special forces, believed to be acting mainly in an advisory role.
"The best work on opening up public information over the past several years has been done within departments and agencies acting mainly on their own initiative," says Boswarva.
When the Pew Centre pollsters asked if America was acting mainly in its own interests in the "war on terrorism", 80% of French people and 85% of Germans agreed.
However, the emerging pattern is something akin to the Hollywood studio system, with the big companies still responsible for some of their own creative output, but acting mainly as banker-distributors for smaller companies' ideas.
He has experience in the electric engineering area, with emphasis in telecommunication systems, acting mainly in the followingexpression is obtainedexpression is obtained subjects: channel coding, digital signal processing, and cognitive radio.
Alpha2-adrenergic receptor (α2-AR) subtypes, acting mainly on the central nervous and cardiovascular systems, represent important targets for drug design, confirmed by the high number of studies published so far.
Objective: Olanzapine is a second generation antipsychotic acting mainly as a dopamine D2 and serotonine 5-HT2 receptors antagonist prescribed in the treatment of schizophrenia and various other psychiatric illnesses.
The regulation of angiogenesis is heavily influenced by a number of growth factors, among which VEGF has been identified as one of the most prominent factors, acting mainly through its endothelial receptor VEGFR2 (also known as Flk-1; Carmeliet and Jain, 2011).
Mebeverine hydrochloride (MEB) 3,4-Dimethoxybenzoic acid 4- [ethyl[2- 4-methoxyphenyl -1-methylethyl]amino]-butylester (Figure 1) is a potent direct antispasmodic acting mainly on the smooth muscles of the gastrointestinal tract and particularly effective against the colonic spasm [ethyl[2- 4-methoxyphenyl -1-methylethyl]amino]-butylester
This work also points out to the discovery of LASSBio-930 (1c) as a novel anti-inflammatory and anti-hyperalgesic prototype, which was able to reduce carrageenan-induced rat paw edema with an ED50 of 97.8 μmol/kg, acting mainly as a non-selective COX inhibitor.
